Skip to main content

Gentamicin Ointment Prescribing Information

Package insert / product label
Generic name: gentamicin sulfate
Dosage form: ointment
Drug class: Topical antibiotics

Medically reviewed by Drugs.com. Last updated on Nov 30, 2023.

Gentamicin Ointment Description

Gentamicin Sulfate Ointment, USP 0.1% is a wide spectrum antibiotic preparation for topical administration. Each gram of Gentamicin Sulfate Ointment, USP 0.1% contains Gentamicin Sulfate USP equivalent to 1 mg of gentamicin base in a base of light mineral oil and white petrolatum, with 0.5 mg methylparaben and 0.1 mg propylparaben as preservatives.

Gentamicin Ointment - Clinical Pharmacology

Gentamicin Sulfate is a wide spectrum antibiotic that provides highly effective topical treatment in primary and secondary bacterial infections of the skin. This product may clear infections that have not responded to other topical antibiotic agents. In impetigo contagiosa and other primary skin infections, treatment with a small amount of Gentamicin Sulfate Ointment three to four times daily usually clears the lesions promptly. In secondary skin infections, the product facilitates the treatment of the underlying dermatosis by controlling the infection. Bacteria susceptible to the action of Gentamicin Sulfate include sensitive strains of Streptococci(group A beta-hemolytic, alphahemolytic), Staphylococcus aureus(coagulase positive, coagulase negative, and some penicillinase-producing strains), and the gram-negative bacteria, Pseudomonas aeruginosa, Aerobacteraerogens, Escherichia coli, Proteus vulgarisand Klebsiellapneumoniae.

Indications and Usage for Gentamicin Ointment

Primary skin infections: Impetigo contagiosa, superficial folliculitis, ecthyma, furunculosis, sycosis barbae, and pyoderma gangrenosum. Secondary skin infections: Infectious eczematoid dermatitis, pustular acne, pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis (including poison ivy), infected excoriations, and bacterial superinfections of fungal or viral infections. NOTE: Gentamicin Sulfate is a bactericidal agent that is not effective against viruses or fungi in skin infections. It is useful in the treatment of infected skin cysts and certain other skin abscesses when preceded by incision and drainage to permit adequate contact between the antibiotic and the infecting bacteria. Good results have been obtained in the treatment of infected stasis and other skin ulcers, infected superficial burns, paronychia, infected insect bites and stings, infected lacerations and abrasions and wounds from minor surgery. Patients sensitive to neomycin can be treated with Gentamicin Sulfate, although regular observation of patients sensitive to topical antibiotics is advisable when such patients are treated with any topical antibiotic. Gentamicin sulfate cream is recommended for wet, oozing primary infections, and greasy, secondary infections, such as postular acne or infected seborrheic dermatitis. Gentamicin Sulfate Ointment, USP 0.1% helps retain moisture and has been useful in infection on dry eczematous or psoriatic skin. Gentamicin Sulfate Ointment, USP 0.1% has been used successfully in infants over one year of age as well as in adults and children.

Contraindications

Gentamicin Sulfate Ointment, USP 0.1% is contraindicated in individuals with a history of sensitivity reactions to any of its components.

Precautions

Use of topical antibiotics occasionally allows overgrowth of nonsusceptible organisms, including fungi. If this occurs, or if irritation, sensitization, or superinfection develops, treatment with Gentamicin Sulfate Ointment, USP 0.1% should be discontinued and appropriate therapy instituted.

Adverse Reactions/Side Effects

In patients with dermatoses treated with Gentamicin Sulfate, irritation (erythema and pruritus) that did not usually require discontinuance of treatment has been reported in a small percentage of cases. There was no evidence of irritation or sensitization, however, in any of these patients patch-tested subsequently with gentamicin on normal skin. Possible photosensitization has been reported in several patients but could not be elicited in these patients by reapplication of gentamicin followed by exposure to ultraviolet radiation.
To report SUSPECTED ADVERSE REACTIONS, contact Cosette Pharmaceuticals, Inc. at 1-800-922-1038 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Gentamicin Ointment Dosage and Administration

A small amount of Gentamicin Sulfate Ointment, USP 0.1% should be applied gently to lesions three to four times a day. The area treated may be covered with a gauze dressing, if desired. In impetigo contagiosa, the crusts should be removed before application of Gentamicin Sulfate Ointment, USP 0.1% to permit maximum contact between the antibiotic and the infection. Care should be exercised to avoid further contamination of the infected skin. Infected stasis ulcers have responded well to Gentamicin Sulfate under gelatin packing.

How is Gentamicin Ointment supplied

Gentamicin Sulfate Ointment, USP 0.1% is available as follows:

15 g tube (NDC 0713- 0682-15)
30 g tube (NDC 0713- 0682-31)


STORAGE
Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].

Distributed by:
Cosette Pharmaceuticals, Inc.
South Plainfield, NJ 07080


Rev. 05/2022
8-0682CPLNC2 VC7635

PRINCIPAL DISPLAY PANEL

NDC 0713-0682-15

Gentamicin Sulfate Ointment, USP 0.1%

15 g

Rx only

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

Cosette Pharmaceuticals, Inc.

15 g Carton

NDC 0713-0682-31

Gentamicin Sulfate Ointment, USP 0.1%

30 g

Rx only

FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.

Cosette Pharmaceuticals, Inc.

30 g Carton

GENTAMICIN SULFATE
gentamicin sulfate ointment
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0713-0682
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GENTAMICIN SULFATE (UNII: 8X7386QRLV) (GENTAMICIN - UNII:T6Z9V48IKG) GENTAMICIN1 mg in 1 g
Inactive Ingredients
Ingredient NameStrength
LIGHT MINERAL OIL (UNII: N6K5787QVP)
PETROLATUM (UNII: 4T6H12BN9U)
METHYLPARABEN (UNII: A2I8C7HI9T)
PROPYLPARABEN (UNII: Z8IX2SC1OH)
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0713-0682-151 in 1 CARTON12/21/2017
115 g in 1 TUBE; Type 0: Not a Combination Product
2NDC:0713-0682-311 in 1 CARTON12/21/2017
230 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA06405411/28/2014
Labeler - Cosette Pharmaceuticals, Inc. (116918230)
Registrant - Cosette Pharmaceuticals, Inc. (116918230)
Establishment
NameAddressID/FEIBusiness Operations
Cosette Pharmaceuticals NC Laboratories, LLC079419931analysis(0713-0682) , label(0713-0682) , manufacture(0713-0682) , pack(0713-0682)